NCT01610713 An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT01610700 An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients Status COMPLETED Phase PHASE3
NCT01610687 A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT01606202 A Study of Cannabis Based Medicine Extracts and Placebo in Patients With Pain Due to Spinal Cord Injury Status COMPLETED Phase PHASE3
NCT01606189 A Study to Compare Sublingual Cannabis Based Medicine Extracts With Placebo to Treat Brachial Plexus Injury Pain Status COMPLETED Phase PHASE3
NCT01606176 A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin Status COMPLETED Phase PHASE3
NCT01604265 A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT01599234 A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT01485770 A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness Status COMPLETED Phase PHASE2
NCT01461915 Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer Patients Status TERMINATED Phase PHASE2
NCT01426295 Pharmaco-economic Study of a New Medical Device Performed From the Perspective of the Hospital Status COMPLETED Phase PHASE2
NCT01424566 A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer Status COMPLETED Phase PHASE3
NCT01401140 Comparing the Protective Effects of Two Cardioplegic Solutions, on Cardiac Metabolism, as Assessed Using Microdialysis Status COMPLETED Phase PHASE3
NCT01361607 Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer Status COMPLETED Phase PHASE3
NCT01337089 Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain Status COMPLETED Phase PHASE3
NCT01323465 Study to Evaluate the Effect of Rifampicin, Ketoconazole, and Omeprazole on the Pharmacokinetics of Sativex Status COMPLETED Phase PHASE1